These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22430965)

  • 1. Action of linezolid or vancomycin on biofilms in ventriculoperitoneal shunts in vitro.
    Bayston R; Ullas G; Ashraf W
    Antimicrob Agents Chemother; 2012 Jun; 56(6):2842-5. PubMed ID: 22430965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of linezolid and vancomycin lock solutions with and without heparin against biofilm-producing bacteria.
    Luther MK; Mermel LA; LaPlante KL
    Am J Health Syst Pharm; 2017 May; 74(9):e193-e201. PubMed ID: 28438824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial activity of linezolid and vancomycin in an in vitro pharmacodynamic model of gram-positive catheter-related bacteraemia.
    Wiederhold NP; Coyle EA; Raad II; Prince RA; Lewis RE
    J Antimicrob Chemother; 2005 May; 55(5):792-5. PubMed ID: 15814598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in vitro activities and postantibiotic effects of the oxazolidinone compounds eperezolid (PNU-100592) and linezolid (PNU-100766) versus vancomycin against Staphylococcus aureus, coagulase-negative staphylococci, Enterococcus faecalis, and Enterococcus faecium.
    Rybak MJ; Cappelletty DM; Moldovan T; Aeschlimann JR; Kaatz GW
    Antimicrob Agents Chemother; 1998 Mar; 42(3):721-4. PubMed ID: 9517963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Activity and penetration of linezolid and vancomycin against Staphylococcus epidermidis biofilms].
    Rodríguez-Martínez JM; Ballesta S; García I; Conejo MC; Pascual A
    Enferm Infecc Microbiol Clin; 2007; 25(7):425-8. PubMed ID: 17692209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms.
    Sandoe JA; Wysome J; West AP; Heritage J; Wilcox MH
    J Antimicrob Chemother; 2006 Apr; 57(4):767-70. PubMed ID: 16464896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-antibiotic growth suppression of linezolid against Gram-positive bacteria.
    Munckhof WJ; Giles C; Turnidge JD
    J Antimicrob Chemother; 2001 Jun; 47(6):879-83. PubMed ID: 11389123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in vitro activity of linezolid and five other antimicrobials against nosocomial isolates of methicillin-resistant Staphylococcus aureus, methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium.
    Metallidis S; Chatzidimitriou M; Nikolaidis P; Tsona A; Bisiklis A; Kollaras P; Tsiakiri E; Koumentaki E; Alexiou-Daniel S
    J Chemother; 2003 Oct; 15(5):442-8. PubMed ID: 14603881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of icaA, atlE and aap genes by linezolid but not vancomycin in Staphylococcus epidermidis RP62A biofilms.
    Reiter KC; Sant'Anna FH; d'Azevedo PA
    Int J Antimicrob Agents; 2014 Mar; 43(3):248-53. PubMed ID: 24389080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative in-vitro evaluation of resistance selection after exposure to teicoplanin, vancomycin, linezolid and quinupristin-dalfopristin in Staphylococcus aureus and Enterococcus spp.
    Drago L; Nicola L; De Vecchi E
    Clin Microbiol Infect; 2008 Jun; 14(6):608-11. PubMed ID: 18397336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of vancomycin, quinupristin/dalfopristin, and linezolid against intact and disrupted biofilms of staphylococci.
    El-Azizi M; Rao S; Kanchanapoom T; Khardori N
    Ann Clin Microbiol Antimicrob; 2005 Jan; 4():2. PubMed ID: 15638934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
    Weigel LM; Donlan RM; Shin DH; Jensen B; Clark NC; McDougal LK; Zhu W; Musser KA; Thompson J; Kohlerschmidt D; Dumas N; Limberger RJ; Patel JB
    Antimicrob Agents Chemother; 2007 Jan; 51(1):231-8. PubMed ID: 17074796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative activity of linezolid against staphylococci and enterococci isolated in Italy.
    Stefani S; Mezzatesta ML; Tempera G; Debbra E; Schito AM; Nicoletti G; Marchére A
    Clin Microbiol Infect; 2002 Jun; 8(6):368-72. PubMed ID: 12084106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activities of Daptomycin, Linezolid, and Quinupristin-Dalfopristin against a challenge panel of Staphylococci and Enterococci, including vancomycin-intermediate staphylococcus aureus and vancomycin-resistant Enterococcus faecium.
    Jevitt LA; Smith AJ; Williams PP; Raney PM; McGowan JE; Tenover FC
    Microb Drug Resist; 2003; 9(4):389-93. PubMed ID: 15000746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of daptomycin or linezolid in combination with rifampin or gentamicin against biofilm-forming Enterococcus faecalis or E. faecium in an in vitro pharmacodynamic model using simulated endocardial vegetations and an in vivo survival assay using Galleria mellonella larvae.
    Luther MK; Arvanitis M; Mylonakis E; LaPlante KL
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4612-20. PubMed ID: 24867993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of biofilm maturation by linezolid in meticillin-resistant Staphylococcus epidermidis clinical isolates: comparison with other drugs.
    Reiter KC; Villa B; Paim TGDS; de Oliveira CF; d'Azevedo PA
    J Med Microbiol; 2013 Mar; 62(Pt 3):394-399. PubMed ID: 23161766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections.
    Curtin J; Cormican M; Fleming G; Keelehan J; Colleran E
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3145-8. PubMed ID: 14506022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linezolid resistance in vancomycin-resistant Enterococcus faecalis and Enterococcus faecium isolates in a Brazilian hospital.
    de Almeida LM; de Araújo MR; Iwasaki MF; Sacramento AG; Rocha D; da Silva LP; Pavez M; de Brito AC; Ito LC; Gales AC; Lincopan N; Sampaio JL; Mamizuka EM
    Antimicrob Agents Chemother; 2014 May; 58(5):2993-4. PubMed ID: 24614366
    [No Abstract]   [Full Text] [Related]  

  • 19. [In vitro activity of linezolid/ertapenem combination in resistant gram-positive bacteria].
    Eraç B; Taşli H; Ermertcan S; Cilli F; Limoncu MH
    Mikrobiyol Bul; 2009 Jan; 43(1):45-51. PubMed ID: 19334379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The post-antibiotic effects of linezolid against Gram-positive pathogens.
    Hosgor-Limoncu M; Ermertcan S; Tasli H; Aydemir S
    Saudi Med J; 2007 Apr; 28(4):551-4. PubMed ID: 17457476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.